<DOC>
	<DOCNO>NCT02540044</DOCNO>
	<brief_summary>This proof-of-concept randomized trial evaluate effectiveness use on-line decision aid ( ANSWER-2 ) decision make start switch biologic therapy Canadian patient rheumatoid arthritis .</brief_summary>
	<brief_title>Supporting Patient Care With Electronic Resource ( SuPER )</brief_title>
	<detailed_description>The propose project aim improve process make evidence-informed treatment decision patient rheumatoid arthritis ( RA ) ultimately , empower patient self-management . Current RA treatment emphasize : 1 ) need early aggressive treatment , 2 ) use Treat-to-Target approach . Patients often struggle treatment decision , however , especially option benefit risk . To address challenge , investigator develop new online decision aid call ANSWER-2 ( ANimated , Self-serve , WEb-based , Research Tool : Version 2 ) RA patient consider biologic new therapy . A unique feature ANSWER-2 ability individualize treatment option present base patient 's preference . Objective : 1 ) To evaluate effectiveness ANSWER-2 reduce patient ' decisional conflict . 2 ) To assess extent ANSWER-2 improve patient ' knowledge RA medication confidence manage health . 3 ) To examine experience patient rheumatologist use ANSWER-2 . The investigator conduct proof-of-concept randomized control trial 148 patient RA . Eligible individual : 1 ) diagnosis RA rheumatologist , 2 ) whose rheumatologist recommend initiate biologic new therapy switch another agent , 3 ) internet access . The Intervention Group receive simple instruction access ANSWER-2 complete program within two day . At end session , one-page summary produce help discuss question , concern , preferred choice health care provider . The Control Group receive The Arthritis Society 's online education booklet `` Arthritis Medications : A Consumer 's Guide '' . Participants complete Decisional Conflict Scale ( primary outcome ) intervention ( ANSWER-2 booklet ) . The following secondary outcome measure collect baseline , 1 month 2 month : 1 ) Medication Education Impact Questionnaire ( MeIQ ) , 2 ) Partners Health Scale ( PHS ) . In addition , use healthcare resource collect 2 month . Participants also ask medication preference Month 1 , well share decision make process last appointment , ( use 3-item CollaboRATE scale ) , Month 1 . Participants receive ANSWER-2 decision aid rheumatologist invite participate interview experience patient decision aid . The investigator use analysis variance ( ANOVA ) compare Intervention Group Control Group , use baseline measure covariate . An iterative content analysis conduct qualitative interview .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>The inclusion criterion follow : 1 ) diagnosis RA rheumatologist , 2 ) whose rheumatologist recommend initiate biologic/subsequent entry biologic switch another biologic agent , 3 ) internet access email . Patients meet inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>